:

BAIDU'S AI CHIP UNIT PLANS DUAL IPO

AI DESK2 MIN READ
FRI, MAY 8, 2026

■ AI-SUMMARIZED FROM 3 SOURCES ▸ TIMELINE

Kunlunxin, Baidu's semiconductor unit, is filing for initial public offerings on both Shanghai's STAR Board and Hong Kong. Baidu maintains a 58% stake in the chip manufacturer.

Baidu Inc.'s artificial intelligence chip division Kunlunxin has announced plans for a dual listing strategy, seeking to raise capital through simultaneous IPOs on Shanghai's STAR Board and Hong Kong's stock exchange. The filings indicate that Kunlunxin will pursue parallel public offerings in both markets, a strategy that allows the company to access investor bases in mainland China and international markets. Shanghai's STAR Board, launched in 2019, functions as China's equivalent to the Nasdaq and has become a key venue for technology and semiconductor companies. Baidu's 58% majority stake in Kunlunxin positions the search giant to benefit substantially from the subsidiary's public market valuation. The move reflects growing demand from investors for exposure to China's semiconductor sector, particularly in specialized chips designed for artificial intelligence applications. Kunlunxin develops processors and accelerators for AI workloads, competing in a sector that has garnered increased attention amid global efforts to advance domestic chip capabilities. The unit's IPO plans come as Chinese tech companies increasingly pursue multi-market listings to diversify funding sources and expand institutional investor reach. The dual listing approach has become more common among Chinese technology firms, allowing them to maintain significant trading volume while capturing investor interest across geographies. Hong Kong listings provide access to international capital, while mainland exchanges offer connections to domestic investors. No specific timeline for the IPOs was disclosed in the filings. The company will need to navigate regulatory approval processes in both jurisdictions before proceeding to public offerings.

■ SOURCES

TechmemeBloomberg TechTechmeme

■ SUMMARY WRITTEN BY AI FROM THE LINKS ABOVE

■ MORE FROM THE STARTUPS DESK

Triomics, an AI platform automating data-heavy tasks for oncologists, secured $22M in Series B funding. The raise follows a $15M Series A in 2024.

18H AGOAI Desk

Xcena secured $135 million in Series B funding at a $570 million valuation for its MX1 chip, which handles data orchestration and KV cache management directly within memory modules.

18H AGOAI Desk

Pittsburgh-based Gray Swan, which stress-tests AI models for frontier labs, secured $40M in Series A funding at a $200M valuation. The round was co-led by Wing VC and Madrona.

YESTERDAYAI Desk

H1, a healthcare SaaS startup, secured $40 million in funding from CVS Health. The investment signals continued investor confidence in specialized software platforms despite AI disruption concerns.

YESTERDAYIndustry Desk

■ SUBSCRIBE TO THE DAILY BRIEF

ONE EMAIL, 5 STORIES, 06:00 UTC. UNSUBSCRIBE ANYTIME.